Pure Global

LIAISON Multi-Control Tumour Markers - Taiwan Registration 363068c39d695d065dc40e757b0099db

Access comprehensive regulatory information for LIAISON Multi-Control Tumour Markers in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 363068c39d695d065dc40e757b0099db and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is MEDRICH INSTRUMENT CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
363068c39d695d065dc40e757b0099db
Registration Details
Taiwan FDA Registration: 363068c39d695d065dc40e757b0099db
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

LIAISON Multi-Control Tumour Markers
TW: ็ฆฎ้›…ๅฐšๅคš้‡่…ซ็˜คๆจ™่จ˜ๅ“็ฎก็‰ฉ่ณช็ต„
Risk Class 2
MD

Registration Details

363068c39d695d065dc40e757b0099db

Ministry of Health Medical Device Import No. 030512

DHA05603051201

Company Information

Italy

Product Details

This product is designed to provide reliability in the analysis of tumor markers (AFP, CA 125 II, CA 15-3, CA 19-9, CEA, Ferritin, HCG and ฮฒ2-Microglobulin) in serum by LIAISON and LIAISON XL automated immunofluorescence analyzers.

A Clinical chemistry and clinical toxicology

A1660 Quality Control Materials (Analytical and Non-Analytical)

Imported from abroad

Dates and Status

Feb 27, 2018

Feb 27, 2028